| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00126334-200407010-00005 |
| P698 | PubMed publication ID | 15213562 |
| P50 | author | Felipe García | Q41350341 |
| Tomàs Pumarola Suñé | Q41886172 | ||
| Douglas F. Nixon | Q44059330 | ||
| Bernard Hirschel | Q66733125 | ||
| Annette Oxenius | Q87490341 | ||
| P2093 | author name string | Catherine Fagard | |
| Montserrat Plana | |||
| Rodney E Phillips | |||
| Ferran Segura | |||
| Mireia Arnedo | |||
| José M Miró | |||
| Gabriel M Ortiz | |||
| Emilio Fumero | |||
| Gabriel Mestre | |||
| Teresa Gallart | |||
| Jose M Gatell | |||
| Maria Antonia Sambeat | |||
| Anna Cruceta | |||
| Anna Lopez | |||
| Lucia Lopalcos | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 791-799 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | Journal of Acquired Immune Deficiency Syndromes | Q6294722 |
| P1476 | title | Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3. | |
| P478 | volume | 36 |
| Q34646987 | A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication |
| Q34764392 | A therapeutic dendritic cell-based vaccine for HIV-1 infection |
| Q39984018 | Assessment of migration of HIV-1-loaded dendritic cells labeled with 111In-oxine used as a therapeutic vaccine in HIV-1-infected patients |
| Q35175897 | Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection |
| Q31106756 | Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine. |
| Q35973632 | HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses |
| Q37051649 | HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection |
| Q92376487 | Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia |
| Q36509570 | Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients. |
| Q36066209 | Interrupting highly active antiretroviral therapy in patients with HIV. |
| Q34717597 | Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo |
| Q39251042 | Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial |
| Q38840779 | Standard vaccines increase HIV-1 transcription during antiretroviral therapy. |
| Q24245709 | Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults |
| Q24245541 | Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults |
| Q34716901 | Structured treatment interruptions with tenofovir monotherapy for simian immunodeficiency virus-infected newborn macaques |
| Q34630184 | Use of RT-defective HIV virions: new tool to evaluate specific response in chronic asymptomatic HIV-infected individuals |
| Q90016230 | Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients |
Search more.